Document Detail

Central-nervous-system stimulants: appraisal of use in geropsychiatric patients.
MedLine Citation:
PMID:  469149     Owner:  NLM     Status:  MEDLINE    
CNS stimulants such as methylphenidate and pentylenetetrazol are currently prescribed for the treatment of aged persons with symptoms of senility. A review of clinical studies conducted with these compounds indicates that firm evidence of efficacy is lacking. Because of the risks associated with high doses of such stimulants in the aged, it would seem that these compounds are of limited utility in geriatric psychiatry.
T Crook
Related Documents :
6613519 - Cerebellar, cortical and functional impairment in toluene abusers.
22039329 - Anti-hepatitis a seroprevalence among chronic viral hepatitis patients in kelantan, mal...
2425459 - What interaction does indoor nitrogen dioxide have on the effect of the automobile exha...
17179529 - Pubertal status and emotional reactivity to a voluntary hyperventilation challenge pred...
16986059 - Pathophysiology of lower urinary tract symptoms in the aging male population.
9695039 - Psychotic symptoms in the elderly: a prospective study in a population sample.
8131299 - Insertion/deletion (i/d) polymorphism at the locus for angiotensin i-converting enzyme ...
19729949 - Forearm length - a new tool to standardize bone parameters of the forearm measured with...
17040499 - Androgenetic alopecia in adolescents: a report of 43 cases.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the American Geriatrics Society     Volume:  27     ISSN:  0002-8614     ISO Abbreviation:  J Am Geriatr Soc     Publication Date:  1979 Oct 
Date Detail:
Created Date:  1979-10-26     Completed Date:  1979-10-26     Revised Date:  2008-03-10    
Medline Journal Info:
Nlm Unique ID:  7503062     Medline TA:  J Am Geriatr Soc     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  476-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Mental Disorders / drug therapy*
Methylphenidate / adverse effects,  therapeutic use*
Pentylenetetrazole / adverse effects,  therapeutic use*
Reg. No./Substance:
113-45-1/Methylphenidate; 54-95-5/Pentylenetetrazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Identification of normal aging and disease-related processes by health care professionals.
Next Document:  The vaginal flora after natural or surgical menopause.